Global Medical Diagnostic Imaging Market Size By Type (X-ray, Ultrasound), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2023 to 2032

The Global Medical/Diagnostic Imaging Market was valued at USD 42.6 billion in 2023 and is projected to reach USD 70.8 billion by 2031, growing at a CAGR of 6.7% during the forecast period (2023–2031). This growth is fueled by the rising prevalence of chronic diseases, increasing aging population, technological advancements in imaging modalities, and the growing demand for early and accurate diagnosis. Medical imaging plays a pivotal role in disease detection, diagnosis, monitoring, and treatment planning, making it indispensable to modern healthcare.

Drivers:

1. Increasing Prevalence of Chronic Diseases:

The global rise in cardiovascular diseases, cancer, neurological disorders, and orthopedic conditions has increased the reliance on diagnostic imaging for effective disease management.

2. Technological Advancements:

Continuous innovations such as AI-enabled imaging systems, 3D/4D imaging, hybrid modalities (PET/CT, SPECT/CT), and portable devices are enhancing accuracy, speed, and patient outcomes.

3. Expansion of Healthcare Infrastructure:

Government and private investments in healthcare infrastructure, particularly in emerging markets, are driving the installation of modern imaging systems in hospitals and diagnostic centers.

Restraints:

1. High Equipment and Maintenance Costs:

Advanced imaging equipment like MRI and PET scanners involve significant capital investment and ongoing operational expenses, limiting adoption in smaller healthcare facilities.

2. Shortage of Skilled Technicians:

A global shortage of radiologists and trained imaging professionals can hinder the optimal utilization of imaging technologies.

Opportunity:

1. Rising Demand for AI-Based Imaging Solutions:

The integration of artificial intelligence in imaging is improving diagnostic accuracy, reducing interpretation time, and automating workflows—opening new avenues for market growth.

2. Expansion in Emerging Markets:

Emerging economies in Asia-Pacific, Latin America, and Africa offer untapped potential with rising healthcare expenditures, growing population, and increasing disease burden.

Market by System Type Insights:

The X-ray imaging segment held the largest market share in 2023, due to its cost-effectiveness and widespread use across clinical applications. However, the MRI and CT imaging segments are expected to witness the fastest growth during the forecast period. MRI offers superior soft tissue imaging, while CT is increasingly preferred for emergency care due to rapid image acquisition capabilities.

Market by End-use Insights:

Hospitals dominated the market in 2023, accounting for over 50% of the global revenue. This is attributed to their comprehensive diagnostic infrastructure, high patient footfall, and availability of multiple imaging modalities. Diagnostic imaging centers are projected to grow significantly, driven by the shift toward outpatient services and cost-effective imaging solutions.

Market by Regional Insights:

North America led the global market in 2023, thanks to advanced healthcare systems, early adoption of new technologies, and favorable reimbursement policies. Asia-Pacific is expected to register the highest CAGR through 2031, supported by increasing healthcare investments, rising medical tourism, and growing awareness of early disease detection.

Competitive Scenario:

Key players in the Global Medical/Diagnostic Imaging Market include GE HealthCare, Siemens Healthineers, Koninklijke Philips N.V., Canon Medical Systems Corporation, Hitachi Ltd., Fujifilm Holdings Corporation, Hologic Inc., Carestream Health, Mindray Medical International, and Esaote SpA. These companies focus on AI integration, product launches, and strategic collaborations to strengthen their market presence.

Notable Developments:

In 2023, GE HealthCare launched a new AI-powered ultrasound system to improve workflow efficiency and diagnostic precision.

Siemens Healthineers introduced a photon-counting CT scanner in 2024, offering enhanced resolution and lower radiation doses.

In 2025, Philips announced a strategic partnership with AWS to integrate cloud-based AI in imaging diagnostics.

Scope of Work – Global Medical/Diagnostic Imaging Market

Report Metric Details

Market Size (2023) USD 42.6 billion

Projected Market Size (2031) USD 70.8 billion

CAGR (2023–2031) 6.7%

Market Segments By System Type (X-ray, MRI, CT, Ultrasound, Nuclear Imaging), By End-use (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers), By Region

Growth Drivers Rise in chronic diseases, technological innovation, healthcare infrastructure expansion

Opportunities AI-based imaging, growth in emerging markets

Key Market Developments:

2023: GE HealthCare launched a new AI-powered ultrasound solution for obstetric and cardiac applications.

2024: Siemens Healthineers unveiled the world’s first photon-counting CT system, enhancing diagnostic accuracy with reduced radiation.

2025: Philips expanded its imaging diagnostics portfolio through cloud-based AI integration in collaboration with Amazon Web Services.

FAQs:

1. What is the current market size of the Global Medical/Diagnostic Imaging Market?

The market was valued at USD 42.6 billion in 2023.

2. What is the major growth driver of the Global Medical/Diagnostic Imaging Market?

The key growth driver is the increasing prevalence of chronic diseases and the need for early, accurate diagnosis.

3. Which is the largest region during the forecast period in the Global Medical/Diagnostic Imaging Market?

North America is currently the largest region, while Asia-Pacific is expected to grow the fastest.

4. Which segment accounted for the largest market share in Global Medical/Diagnostic Imaging Market?

The X-ray imaging segment accounted for the largest market share in 2023.

5. Who are the key market players in the Global Medical/Diagnostic Imaging Market?

Key players include GE HealthCare, Siemens Healthineers, Philips, Canon Medical, Hitachi, and Fujifilm Holdings.